45th week of 2018 patent applcation highlights part 25 |
Patent application number | Title | Published |
20180319775 | INHIBITORS OF KRAS G12C MUTANT PROTEINS | 2018-11-08 |
20180319776 | NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIHGHT-EMITTING DIODE COMPRISING SAME | 2018-11-08 |
20180319777 | CRYSTALLINE FORMS OF POSACONAZOLE INTERMEDIATE AND PROCESS FOR THE PREPARATION OF AMORPHOUS POSACONAZOLE | 2018-11-08 |
20180319778 | PHENYL INDOLE ALLOSTERIC INHIBITORS OF P97 ATPASE | 2018-11-08 |
20180319779 | SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF | 2018-11-08 |
20180319780 | INHIBITORS OF JUN N-TERMINAL KINASE | 2018-11-08 |
20180319781 | NEW BENZIMIDAZOLES DERIVATIVES AS TEC KINASES FAMILY INHIBITORS | 2018-11-08 |
20180319782 | N-((HET) ARYLMETHYL)-HETEROARYL-CARBOXAMIDES COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS | 2018-11-08 |
20180319783 | Novel Ferroportin Inhibitors | 2018-11-08 |
20180319784 | PHENYLTHIAZOLES AND USES THEREOF | 2018-11-08 |
20180319785 | 4-HYDROXY-2-PHENYL-1,3-THIAZOL-5-YL METHANONE DERIVATIVES AS TRPM8 ANTAGONISTS | 2018-11-08 |
20180319786 | INHIBITOR OF THE P2X7 RECEPTOR | 2018-11-08 |
20180319787 | BACE1 INHIBITORS | 2018-11-08 |
20180319788 | N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY | 2018-11-08 |
20180319789 | PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAININGSUBSTITUENTS | 2018-11-08 |
20180319790 | PREPARATION METHODS FOR PALBOCICLIB FREE BASE CRYSTAL FORM A AND CRYSTAL FORM B | 2018-11-08 |
20180319791 | 4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE AND 1,4,5,6,7,8-HEXAHYDROIMIDAZO[4,5-D]AZEPINE DERIVATIVES AS JANUS KINASE INHIBITORS | 2018-11-08 |
20180319792 | PYRROLOQUINOLINE QUINONE B CRYSTAL FORM AND PREPARATION METHOD THEREFOR | 2018-11-08 |
20180319793 | HISTONE DEMETHYLASE INHIBITORS | 2018-11-08 |
20180319794 | AMINO-SUBSTITUTED IMIDAZO[1,2-A] PYRIDINECARBOXAMIDES AND THEIR USE | 2018-11-08 |
20180319795 | THERAPEUTIC TARGETING OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK4) IN CANCERS CHARACTERIZED BY REARRANGEMENTS IN THE MIXED LINEAGE LEUKEMIA GENE (MLL-r) | 2018-11-08 |
20180319796 | JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease | 2018-11-08 |
20180319797 | NOVEL SUBSTITUTED PYRIDO-PIPERAZINONE DERIVATIVES AS GAMMA SECRETASE MODULATORS | 2018-11-08 |
20180319798 | 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyrazine Derivative and Use of the Same as HIV Integrase Inhibitor | 2018-11-08 |
20180319799 | PYRIDO[1,2-A]PYRIMIDONE ANALOG, CRYSTAL FORM THEREOF, INTERMEDIATE THEREOF AND PREPARATION METHOD THEREFOR | 2018-11-08 |
20180319800 | (1R,4R) 7-OXO-2-AZABICYCLO[2.2.2]OCT-5-ENE AND DERIVATIVES THEREOF | 2018-11-08 |
20180319801 | INHIBITORS OF CYCLIN-DEPENDENT KINASES | 2018-11-08 |
20180319802 | Method Of Stabilizing Riboflavin | 2018-11-08 |
20180319803 | SALT AND POLYMORPHIC FORMS OF (3R,4S)-L-((4-AMINO-5H-PYRROLO[3,2,-D]PYRIMIDIN-7-YL)METHYL)-4(METHYLTHIO- METHYL)PYRODIN-3-OL(MTDIA) | 2018-11-08 |
20180319804 | NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | 2018-11-08 |
20180319805 | CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR | 2018-11-08 |
20180319806 | CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR | 2018-11-08 |
20180319807 | [8-(PHENYLSULFONYL)-3,8-DIAZABICYCLO[3.2.1]OCT-3-YL](1H-1,2,3-TRIAZOL-4-YL- )METHANONES | 2018-11-08 |
20180319808 | METHOD FOR PRODUCING A SPIROOXINDOLE DERIVATIVE | 2018-11-08 |
20180319809 | FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | 2018-11-08 |
20180319810 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | 2018-11-08 |
20180319811 | DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS | 2018-11-08 |
20180319812 | HETEROCYCLIC COMPOUND | 2018-11-08 |
20180319813 | BENZIMIDAZOLE FUSED HETEROARYLS | 2018-11-08 |
20180319814 | CORTISTATIN ANALOGUES AND SYNTHESES AND USES THEREOF | 2018-11-08 |
20180319815 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | 2018-11-08 |
20180319816 | PRODUCTION METHOD OF THIENOPYRIMIDINE DERIVATIVE | 2018-11-08 |
20180319817 | Derivatized 3-Styryl-Cephalosporins | 2018-11-08 |
20180319818 | ACTIVATORS OF AUTOPHAGIC FLUX AND PHOSPHOLIPASE D AND CLEARANCE OF PROTEIN AGGREGATES INCLUDING TAU AND TREATMENT OF PROTEINOPATHIES | 2018-11-08 |
20180319819 | HETEROCYCLIC COMPOUND | 2018-11-08 |
20180319820 | Novel 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative | 2018-11-08 |
20180319821 | COVALENT ORGANIC FRAMEWORKS WITH A WOVEN STRUCTURE | 2018-11-08 |
20180319822 | Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release | 2018-11-08 |
20180319823 | MIXTURES OF CYCLIC BRANCHED SILOXANES OF THE D/T TYPE AND CONVERSION PRODUCTS THEREOF | 2018-11-08 |
20180319824 | MOISTURE AND ROOM TEMPERATURE-CURABLE ORGANOPOLYSILOXANE RESIN COMPOSITION AND METHOD FOR PRODUCING CURED PRODUCT THEREOF | 2018-11-08 |
20180319825 | CELL-PENETRATING, GUANIDINIUM-RICH OLIGOPHOSPHOTRIESTERS FOR DRUG AND PROBE DELIVERY | 2018-11-08 |
20180319826 | PROCESS FOR ISOLATING A (THIO)PHOSPHORIC ACID DERIVATIVE | 2018-11-08 |
20180319827 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING CYANOHYDRIN ESTERS | 2018-11-08 |
20180319828 | PREPARATION METHOD FOR TEDIZOLID, TEDIZOLID INTERMEDICATE, AND PREPARATION METHOD THEREFOR | 2018-11-08 |
20180319829 | PHOSPHINIC PEPTIDE DERIVATIVES FOR USE AS MMP-12 INHIBITORS | 2018-11-08 |
20180319830 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2018-11-08 |
20180319831 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2018-11-08 |
20180319832 | Design, Synthesis, and Biological Activity of Platinum-benz[c]acridine Hybrid Agents and Methods Associated Therewith | 2018-11-08 |
20180319833 | Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-D-mannose | 2018-11-08 |
20180319834 | THIONUCLEOSIDE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION | 2018-11-08 |
20180319835 | METHOD OF PREPARING NUCLEASE-RESISTANT DNA-INORGANIC HYBRID NANOFLOWERS | 2018-11-08 |
20180319836 | BILE ACID DERIVATIVES AND METHODS FOR SYNTHESIS AND USE | 2018-11-08 |
20180319837 | METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING PARKINSON'S DISEASE | 2018-11-08 |
20180319838 | CONJUGATION METHODS FOR MODIFYING OR IMMOBILIZING PROTEINS | 2018-11-08 |
20180319839 | GELATINASE INHIBITORS AND USE THEREOF | 2018-11-08 |
20180319840 | NOVEL ANTIMICROBIAL PEPTIDE AND USE THEREOF | 2018-11-08 |
20180319841 | AGONIST OF SPEXIN-BASED GALANIN TYPE 2 RECEPTOR AND USE THEREOF | 2018-11-08 |
20180319842 | COMPOUNDS AND METHODS FOR TREATING PAIN | 2018-11-08 |
20180319843 | COMPOSITIONS AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM (CNS) DISORDERS AND MOOD DISORDERS | 2018-11-08 |
20180319844 | CYCLIC PEPTIDE BINDER AGAINST ONCOGENIC K-RAS | 2018-11-08 |
20180319845 | VACCINES AGAINST HEPATITIS B VIRUS | 2018-11-08 |
20180319846 | PREFUSION RSV F PROTEINS AND THEIR USE | 2018-11-08 |
20180319847 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO EPHRIN SIGNALING WITH CUPREDOXINS | 2018-11-08 |
20180319848 | MODIFICATIONS OF CUPREDOXIN DERIVED PEPTIDES AND METHODS OF USE THEREOF | 2018-11-08 |
20180319849 | METHODS OF ANALYZING CELL MEMBRANES | 2018-11-08 |
20180319850 | CRISPR-ASSOCIATED (Cas) PROTEINS WITH REDUCED IMMUNOGENICITY | 2018-11-08 |
20180319851 | WAP GENES AND PROTEINS THAT IMPROVE BACILLUS COMPETITIVENESS | 2018-11-08 |
20180319852 | Increased production of ginsenosides through yeast cell organelle improvement | 2018-11-08 |
20180319853 | METHODS AND COMPOSITIONS FOR RED-SHIFTED CHROMOPHORE SUBSTITUTION FOR OPTOGENETIC APPLICATIONS | 2018-11-08 |
20180319854 | EXPRESSION IN MAMMALIAN CELLS WITH GAUSSIA LUCIFERASE SIGNAL PEPTIDE | 2018-11-08 |
20180319855 | GENETICALLY MUTATED AEQUORIN-BASED BIOSENSORS WITH EXTRA SENSITIVITY TO CALCIUM AND IMPROVED BIOLUMINESCENCE INTENSITY | 2018-11-08 |
20180319856 | EPITOPES IN AMYLOID BETA MID-REGION AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO | 2018-11-08 |
20180319857 | FGF2 TRUNCATIONS AND MUTANTS AND USES THEREOF | 2018-11-08 |
20180319858 | PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING HUMAN PAPILLOMAVIRUS-CAUSED DISEASES | 2018-11-08 |
20180319859 | INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS | 2018-11-08 |
20180319860 | ISLET AMYLOID POLYPEPTIDES WITH IMPROVED SOLUBILITY | 2018-11-08 |
20180319861 | COMBINATION THERAPY FOR MALIGNANT DISEASES | 2018-11-08 |
20180319862 | CHIMERIC RECEPTORS CONTAINING TRAF-INDUCING DOMAINS AND RELATED COMPOSITIONS AND METHODS | 2018-11-08 |
20180319863 | ANTI-HLA ASSAY AND METHODS | 2018-11-08 |
20180319864 | METHODS AND COMPOSITIONS FOR MODIFICATION OF A HLA LOCUS | 2018-11-08 |
20180319865 | Identification of Novel Small Molecule Beta2 Integrin Agonists | 2018-11-08 |
20180319866 | HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF MAKING THEREOF | 2018-11-08 |
20180319867 | POLYMERIZED PEPTIDE AND GEL HAVING COLLAGEN-LIKE STRUCTURE | 2018-11-08 |
20180319868 | SERPIN REACTIVE CENTER LOOP PEPTIDES AND METHODS OF USE | 2018-11-08 |
20180319869 | METHOD FOR MASS HUMANIZATION OF RABBIT ANTIBODIES | 2018-11-08 |
20180319870 | METHODS TO CREATE CHEMICALLY-INDUCED DIMERIZING PROTEIN SYSTEMS FOR REGULATION OF CELLULAR EVENTS | 2018-11-08 |
20180319871 | Antibody Preparations | 2018-11-08 |
20180319872 | YEAST-BASED IMMUNOTHERAPY AGAINST CLOSTRIDIUM DIFFICILE INFECTION | 2018-11-08 |
20180319873 | Antibodies Against Infectious Diseases | 2018-11-08 |
20180319874 | Single Chain Intrabodies that Alter Huntingtin Mutant Degradation | 2018-11-08 |